產(chǎn)品詳情
簡(jiǎn)單介紹:
LFM-A13
詳情介紹:
Characteristics | FM-A13 is a selective inhibitor of Bruton's tyrosine kinase (BTK) IC50's = 2.5 μM (recombinant BTK) and 17.2 μM (human BTK). It has also been shown to inhibit Polo-like kinase (PLK) (IC50= 61 μM for human PLK3). It displays no activity (concentrations up to 278 μM) at JAK1, JAK3, HCK, EGFRK and IRK2 or CDK1-3, CHK1, IKK, MAPK1, SAPK2a and ten tyrosine kinases. |
Purity | ≥ 98?% by TLC |
Chemical Name | (2Z) -2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide |
Formula | C??H?Br2N?O? |
Permeability | Cell-permeable |
Molecular Weight | 360 g/mol |
CAS-No | 244240-24-2 |
Restrictions | For Research Use only |
Format | Solid |
Handling Advice | Protect from light and air |
Storage | -20 °C |
Expiry Date | 36 months |
Supplier Images |
|